IDL Biotech Q4: Impressive sales
Research Note
2020-02-20
11:15
IDL reported significantly higher sales than we had expected for the fourth quarter, growing with 53% YoY. Consequently, IDL showed a positive EBIT on quarterly basis for the first time in a long time.
LS
Ludvig Svensson
Disclosures and disclaimers